3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
2
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Thoracic
2
Classical hematology
2
Myeloid
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Breast
1
Conditions
Venous Thromboembolism
2
Venous Thrombosis
1
Thrombosis
1
Pulmonary Embolism
1
Neoplasms
1
Interventions
fludarabine phosphate
58
Cyclophosphamide
54
Epoetin Alfa
43
Cyclosporine
43
Busulfan
43
Peripheral Blood Stem Cell Transplantation
39
Mycophenolic Acid
34
Darbepoetin alfa
33
Antilymphocyte Serum
31
Whole-Body Irradiation
30
Cytarabine
30
Filgrastim
29
Methotrexate
26
Tacrolimus
25
Radiotherapy
25
Melphalan
24
fludarabine
21
Methylprednisolone
17
Cord Blood Stem Cell Transplantation
17
Etoposide
14
Granulocyte Colony-Stimulating Factor
13
Daunorubicin
13
Rivaroxaban
12
apixaban
11
Thiotepa
11
sargramostim
10
epoetin beta
10
Dalteparin
10
eltrombopag
9
Alemtuzumab
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Dabigatran
×
Classical hematology
×
Clear all
NCT02744092
2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA
Completed
811 enrolled
19 charts
NCT03965741
2021-11-30
PRACTISE
Bayer
Completed
97,765 enrolled